Search research articles
Contact Us
Filters
Showing results (251-260 of 298) with videos related to
Page
of 30
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 8, 2026
Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure
Yining Xie, Sanjeevini Babu Reddiar, Dan Zheng, et al.
Antioxidants & Redox Signaling
|
February 4, 2020
Spatial Properties of Reactive Oxygen Species Govern Pathogen-Specific Immune System Responses
Eunice E To, John J O'Leary, Luke A J O'Neill, et al.
Pharmaceutical Research
|
July 28, 2007
Low dose lipid formulations: effects on gastric emptying and biliary secretion
Greg A Kossena, William N Charman, Clive G Wilson, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 8, 2015
Molecular weight (hydrodynamic volume) dictates the systemic pharmacokinetics and tumour disposition of PolyPEG star polymers
Song Yang Khor, Jinming Hu, Victoria M McLeod, et al.
Journal of Pharmaceutical Sciences
|
April 6, 2024
Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine
Yining Xie, Zijun Lu, Ian K Styles, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2016
Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function
Yijun Pan, Jennifer L Short, Kwok H C Choy, et al.
Pharmaceutical Research
|
October 22, 2015
A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep
Gemma M Ryan, Robert J Bischof, Perenlei Enkhbaatar, et al.
Advanced Drug Delivery Reviews
|
June 1, 2019
Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms
Hywel D Williams, Leigh Ford, Annabel Igonin, et al.
Molecular Pharmaceutics
|
February 11, 2025
Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
Luojuan Hu, Tim Quach, Dan Zheng, et al.
Journal of Pharmaceutical Sciences
|
July 3, 2014
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system
Hywel D Williams, Philip Sassene, Karen Kleberg, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 298) with videos related to
Sort By:
Page
of 30
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
July 8, 2026
Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure
Yining Xie, Sanjeevini Babu Reddiar, Dan Zheng, et al.
Antioxidants & Redox Signaling
|
February 4, 2020
Spatial Properties of Reactive Oxygen Species Govern Pathogen-Specific Immune System Responses
Eunice E To, John J O'Leary, Luke A J O'Neill, et al.
Pharmaceutical Research
|
July 28, 2007
Low dose lipid formulations: effects on gastric emptying and biliary secretion
Greg A Kossena, William N Charman, Clive G Wilson, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 8, 2015
Molecular weight (hydrodynamic volume) dictates the systemic pharmacokinetics and tumour disposition of PolyPEG star polymers
Song Yang Khor, Jinming Hu, Victoria M McLeod, et al.
Journal of Pharmaceutical Sciences
|
April 6, 2024
Lymphatic Uptake of a Highly Lipophilic Protease Inhibitor Prodrug from a Lipid-Based Formulation is Limited by Instability in the Intestine
Yining Xie, Zijun Lu, Ian K Styles, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2016
Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function
Yijun Pan, Jennifer L Short, Kwok H C Choy, et al.
Pharmaceutical Research
|
October 22, 2015
A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep
Gemma M Ryan, Robert J Bischof, Perenlei Enkhbaatar, et al.
Advanced Drug Delivery Reviews
|
June 1, 2019
Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms
Hywel D Williams, Leigh Ford, Annabel Igonin, et al.
Molecular Pharmaceutics
|
February 11, 2025
Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport
Luojuan Hu, Tim Quach, Dan Zheng, et al.
Journal of Pharmaceutical Sciences
|
July 3, 2014
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system
Hywel D Williams, Philip Sassene, Karen Kleberg, et al.
Page
of 30